English | 简体中文 | 繁體中文 | 한국어
 English Press Releases
 Medicine BioTech
Singapore Scientists Develop DNA-altering Technology to Tackle Diseases
Sep 13, 2016 17:30 HKT
Helsinn and PatientsLikeMe Announce Results of NSCLC Patient Survey on Weight Loss
Sep 09, 2016 21:30 HKT
The Sixth U.S.-China Health Summit Opened in Xi'an
Sep 05, 2016 17:26 HKT
Jointly Establishing the International Land Port Hospital; Universal Medical and First Affiliated Hospital of Xi'an Jiaotong University to Sign the Official Agreement
Aug 31, 2016 16:47 HKT
Uni-Bio Science Group Announces 2016 Interim Results
Aug 26, 2016 20:14 HKT
Shanghai Pharmaceuticals Released 2016 Interim Results
Aug 25, 2016 23:20 HKT
Lee's Pharm 2016 Interim Net Profit Up 17.9%
Aug 25, 2016 19:00 HKT
NT Pharma Announces 2016 Interim Results
Aug 18, 2016 20:02 HKT
Singapore Scientists Grow Mini Human Brains
Jul 29, 2016 00:00 HKT
Singapore-based Luye Medical Group Signs MOU with China's City of Chongqing for RMB2B Strategic Partnership
Jul 26, 2016 17:15 HKT
Luye Pharma Takes a Milestone Step Forward; Proposed Acquisition of Acino's TDS Business
Jul 26, 2016 08:45 HKT
A*STAR and MSD Establish a New Research Collaboration to Advance Peptide Therapeutics
Jul 20, 2016 10:00 HKT
Singapore Scientists Discover New Pathways Leading to Cancer Progression
Jul 18, 2016 10:00 HKT
Study Finds Strong Genetic Risk Factor for Kidney Disease
Jul 13, 2016 10:00 HKT
A New Way to Diagnose and Treat Lung Cancer
Jul 12, 2016 10:00 HKT
Hepatitis B Clinical Trial opens in Australia
Jul 12, 2016 06:00 HKT
A New Way of Looking at Cancer
Jul 08, 2016 16:00 HKT
Nanobiotix Reports Successful Results from Phase I/II Trial of NBTXR3 in Head & Neck Cancer
Jul 07, 2016 11:00 HKT
Neste Jacobs Playing a Major Role in Asia's Largest Biopharma Project
Jun 29, 2016 15:00 HKT
Uni-Bio Science Group Announces 2015 Annual Results
Jun 14, 2016 08:06 HKT
<< Previous  Next >>
Copyright © 2026 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 214 890 4418 | Beijing: +86 400 879 3881 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575

Connect With us: